142 related articles for article (PubMed ID: 35619199)
21. An intrathoracic schwannoma case in
Gültekin A; Aydoğmuş Ü; Arifoğlu H; Bir F; Yaylalı O
Hell J Nucl Med; 2020; 23(2):206-208. PubMed ID: 32716413
[TBL] [Abstract][Full Text] [Related]
22. Detection of synchronous gastric schwannoma on FDG PET/CT aided by discordant metabolic response.
Yap J; Huang YT; Lin M
Clin Nucl Med; 2015 May; 40(5):e287-9. PubMed ID: 25706785
[TBL] [Abstract][Full Text] [Related]
23. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
[TBL] [Abstract][Full Text] [Related]
24. Imaging of renal cell carcinoma in patients with acquired cystic disease of the kidney: comparison
Kitajima K; Yamamoto S; Kawanaka Y; Katsuura T; Fujita M; Nakanishi Y; Yamada Y; Hashimoto T; Suzuki T; Go S; Kanematsu A; Nojima M; Yamakado K
Jpn J Radiol; 2019 Feb; 37(2):165-177. PubMed ID: 30377936
[TBL] [Abstract][Full Text] [Related]
25. FDG-PET/CT of schwannomas arising in the brachial plexus mimicking lymph node metastasis: report of two cases.
Fujii T; Yajima R; Morita H; Yamaguchi S; Tsutsumi S; Asao T; Kuwano H
World J Surg Oncol; 2014 Oct; 12():309. PubMed ID: 25306157
[TBL] [Abstract][Full Text] [Related]
26. Incidental Finding of a Tongue Schwannoma Mimicking Local Recurrence of Squamous Cell Carcinoma on a Systematic Follow-up 18F-FDG PET/CT.
Dzuko Kamga J; Leclere JC; Conan-Charlet V; Tissot V; Abgral R
Clin Nucl Med; 2023 Feb; 48(2):e92-e94. PubMed ID: 36607382
[TBL] [Abstract][Full Text] [Related]
27. FDG PET/CT of Intercostal Schwannoma.
Wang SY; Luo DL; Chen G; Liu ET; Wang SX
Clin Nucl Med; 2016 Jun; 41(6):e310-2. PubMed ID: 26859215
[TBL] [Abstract][Full Text] [Related]
28. One-month assessment of renal cell carcinoma treated by everolimus using FDG PET/CT predicts progression-free and overall survival.
Ito H; Kondo K; Kawahara T; Kaneta T; Tateishi U; Ueno D; Namura K; Kobayashi K; Miyoshi Y; Yumura Y; Makiyama K; Hayashi N; Hasumi H; Osaka K; Yokomizo Y; Teranishi JI; Hattori Y; Inoue T; Uemura H; Yao M; Nakaigawa N
Cancer Chemother Pharmacol; 2017 May; 79(5):855-861. PubMed ID: 28331985
[TBL] [Abstract][Full Text] [Related]
29. Role of Positron Emission Tomography Imaging in Metabolically Active Renal Cell Carcinoma.
Karivedu V; Jain AL; Eluvathingal TJ; Sidana A
Curr Urol Rep; 2019 Aug; 20(10):56. PubMed ID: 31468240
[TBL] [Abstract][Full Text] [Related]
30. Significance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma.
Park JW; Jo MK; Lee HM
BJU Int; 2009 Mar; 103(5):615-9. PubMed ID: 19007371
[TBL] [Abstract][Full Text] [Related]
31. Role of F-18 FDG PET/CT in the follow-up of asymptomatic renal cell carcinoma patients for postoperative surveillance: based on conditional survival analysis.
Park S; Lee HY; Lee S
J Cancer Res Clin Oncol; 2022 Jan; 148(1):215-224. PubMed ID: 34106327
[TBL] [Abstract][Full Text] [Related]
32. 18F-FDG PET/CT in a patient affected by renal collecting duct (Bellini) carcinoma.
Bertagna F; Fisogni S; Tardanico R; Simeone C; Cunico SC; Giubbini R
Clin Nucl Med; 2012 Oct; 37(10):986-8. PubMed ID: 22955073
[TBL] [Abstract][Full Text] [Related]
33. PET/CT and contrast-enhanced CT imaging findings in benign solitary schwannomas.
Wang SY; Liu JH; Yao S; Wang SX; Shao D
Eur J Radiol; 2021 Aug; 141():109820. PubMed ID: 34139574
[TBL] [Abstract][Full Text] [Related]
34. 68Ga-PSMA PET/CT and 18F-FDG PET/CT in Renal Cell Carcinoma.
Chen EJ; Tan TH; Chew MT; Chye PC
Clin Nucl Med; 2020 Jul; 45(7):e317-e319. PubMed ID: 32404702
[TBL] [Abstract][Full Text] [Related]
35. Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign.
Benz MR; Czernin J; Dry SM; Tap WD; Allen-Auerbach MS; Elashoff D; Phelps ME; Weber WA; Eilber FC
Cancer; 2010 Jan; 116(2):451-8. PubMed ID: 19924789
[TBL] [Abstract][Full Text] [Related]
36. Renal Mucinous Tubular and Spindle Cell Carcinoma Shows a High Uptake on
Furuya S; Manabe O; Nanbu T; Yamashita N; Shinnno Y; Kasai K; Kroenke M; Tamaki N
Intern Med; 2018 Apr; 57(8):1131-1134. PubMed ID: 29279490
[TBL] [Abstract][Full Text] [Related]
37. FDG PET/CT in a Case of Thoracic SMARCA4-Deficient Undifferentiated Tumor.
Guo J; Liao Z; Chen Q; Dong A; Huang M
Clin Nucl Med; 2023 Dec; 48(12):1111-1113. PubMed ID: 37882056
[TBL] [Abstract][Full Text] [Related]
38. Gastric Schwannoma mimicking malignant gastrointestinal stromal tumor and misdiagnosed by (18)F-FDG PET/CT.
Zhang Y; Li B; Cai L; Hou X; Shi H; Hou J
Hell J Nucl Med; 2015; 18(1):74-6. PubMed ID: 25840576
[TBL] [Abstract][Full Text] [Related]
39. Complimentary Pattern of Uptake in 18F-FDG PET/CT and 68Ga-Prostate-Specific Membrane Antigen PET/CT in a Case of Metastatic Clear Cell Renal Carcinoma.
Sasikumar A; Joy A; Nanabala R; Unni M; Tk P
Clin Nucl Med; 2016 Dec; 41(12):e517-e519. PubMed ID: 27749421
[TBL] [Abstract][Full Text] [Related]
40. FDG PET/CT and CT Findings of Renal Cell Carcinoma With Sarcomatoid Differentiation.
Zhu H; Zhao S; Zuo C; Ren F
AJR Am J Roentgenol; 2020 Sep; 215(3):645-651. PubMed ID: 32755159
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
